Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 4
1995 5
1996 5
1997 4
1998 7
1999 4
2000 6
2001 4
2002 5
2003 3
2004 3
2005 12
2006 6
2007 26
2008 31
2009 22
2012 1
2014 1
2015 1
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 18214053

145 results
Results by year
Filters applied: . Clear all
Page 1
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B. Yeo W, et al. Breast Cancer Res Treat. 2009 Feb;113(3):529-35. doi: 10.1007/s10549-008-9957-9. Epub 2008 Mar 10. Breast Cancer Res Treat. 2009. PMID: 18327706 Clinical Trial.
Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: a multicenter, double-masked study. Ondansetron Orally Disintegrating Tablet Emesis Study Group.
Davidson N, Rapoport B, Erikstein B, L'Esperance B, Ruff P, Paska W, Miller I, Curtis P. Davidson N, et al. Clin Ther. 1999 Mar;21(3):492-502. doi: 10.1016/s0149-2918(00)88304-6. Clin Ther. 1999. PMID: 10321418 Clinical Trial.
[Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs].
Nukariya N, Niitani H, Taguchi T, Furue H, Ota K, Tsukagoshi S, Ariyoshi Y, Ikeda M, Akasaka Y, Ohta J, et al. Nukariya N, et al. Gan To Kagaku Ryoho. 1992 Aug;19(9):1347-57. Gan To Kagaku Ryoho. 1992. PMID: 1386976 Clinical Trial. Japanese.
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F. Warr DG, et al. J Clin Oncol. 2005 Apr 20;23(12):2822-30. doi: 10.1200/JCO.2005.09.050. J Clin Oncol. 2005. PMID: 15837996 Free article. Clinical Trial.
145 results